FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)

Kalshi Health › FDA & drugs Closed Oct 21 · $4K traded · $1.4K at stake

Embed

Settled YesA day before, traders gave it 95%.

The last odds before it closed

95%chance

How the odds have moved

Yes: 96% on Oct 20, 95% now.

Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.

Every outcome

Outcome Last odds Day Bid Ask Pays Contracts
✓ Yes 95% 4.2K

"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".

The news: FDA, Bepirovirsen, GlaxoSmithKline

Search ›
  • FDA Approves Bepirovirsen as First Treatment Offering a Functional Cure for Chronic Hepatitis BScience Times · 4 days agoThe U.S. Food and Drug Administration (FDA) has approved bepirovirsen, sold under the brand name Hibsago, as a new treatment for certain adults with chronic hepatitis B. The approval introduces the first antisense oligonucleotide treatment…
  • Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen@AJMC_Journal · 3 days agoPresented by The Community Oncology Alliance Hepatitis B functional cure with bepirovirsen held in 90% to 92% of responders 48 weeks after stopping all therapy, per data at The Liver Meeting 2026. Because the B-Well trials did not enroll…
  • FDA grants tentative approval to low-cost HIV shotsemafor.com · 5 days agoThe potential rollout of a more affordable injection to help prevent HIV infection lifts hopes for reduced AIDS deaths in Africa. US regulators’ approval of a cheaper HIV shot has lifted hopes in some of the world’s poorest countries…
  • FDA Approval for BENLYSTA issued to GLAXOSMITHKLINE LLCQuantisnow · 6 days agoFDA approved SUPPL-38 label update for BENLYSTA (belimumab) BLA 761043 on 10/30/2026; no new indication or pricing detail disclosed. Plus members following GSK got this by push and email at 17:45:48 ET - 2.9s after publication. The FDA…
  • GlaxoSmithKline Pharmaceuticals NSE:GLAXO Analyst Meet 2026Kalkine India · 5 days agoKalkine India GlaxoSmithKline Pharmaceuticals (NSE:GLAXO): What Did the Analyst Meet Presentation Cover? Source: Krish Capital Pty Ltd GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) submitted a regulatory filing to both BSE and NSE on…
  • Pharma critic Bernie Sanders is set to hold major sway over FDA funding billSTAT · 5 days agoSTAT WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a key funding source for the Food and Drug Administration in part by empowering a major critic of…
  • FDA Upgrades Recall of Gelatelli-Brand GelatoNTD · 3 days agoThe lot of Gelatelli coffee and vanilla gelato that was withdrawn from the market last month was flagged by the U.S. Food and Drug Administration (FDA) as a Class I recall event this week. Concerns about the potential for Listeria…
  • FDA Recall Update: FebruaryPowder Bulk Solids · 4 days agoThere were 14 recalls in the food & beverage, pet food, and drugs sectors, a 25% decrease compared with last month. The US Food & Drug Administration (FDA) recalled 14 food and beverage, pet food, and drugs products, and updated a previous…
  • FDA probes tumour risk tied to Novartis gene therapyTradingView · 3 days agoTradingView FDA probes tumour risk tied to Novartis gene therapy
  • FDA Approves Amivantamab for Recurrent or Metastatic HNSCC@OncNursingNews · 3 days agoFDA grants accelerated approval to amivantamab and hyaluronidase-lpuj for recurrent or metastatic head and neck squamous cell carcinoma. The approval was based on cohort 1 of the open-label, multicenter phase 1b/2 OrigAMI-4 trial, which…
  • FlowStop Hemostatic Spray Hits 18,000 Units, Seeks FDA ClearanceBioSpace · 3 days agoSouth Korean maker INNOPHARMA designs the no-compression liquid spray for bystanders, firefighters and soldiers who reach injuries before medical care DAEGU, South Korea, Nov. 6, 2026 /PRNewswire/ -- A liquid spray lets people without…
  • FDA Upgrades Frozen Blueberry RecallPowder Bulk Solids · 4 days agoThe federal agency classified the recalled product, sold by supermarket chain Publix, as Class I, which represents the highest level of risk. On Tuesday, the US Food & Drug Administration (FDA) upgraded a growing recall on frozen…

Related markets

All fda & drugs ›

Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Progressives. Prices read from the venues just now. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.

Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Progressives, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Progressives index; prices of stocks, rates and coins from 4Progressives Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions